华大基因：股东生华投资减持计划届满累计减持1.1487%股份

Group 1 - The core point of the article is that BGI Genomics (300676) announced the completion of a share reduction plan by a major shareholder, Shenzhen Shenghua Investment Enterprise (Limited Partnership) [1] - The shareholder reduced its stake by a total of 4,805,301 shares, which represents 1.1487% of the company's total share capital [1]